Key result
Beta-blocker therapy in patients undergoing coronary angiography was associated with a lower central-to-peripheral systolic blood pressure ratio compared to no beta-blockers (0.89 vs 0.93; P=0.016).
Why the study?
The study aimed to propose the ratio of central to peripheral blood pressure as a novel index to predict cardiovascular risk and assess the impact of beta-blocker therapy on this ratio.
Does beta-blocker therapy impact the central:peripheral blood pressure ratio in patients undergoing coronary angiography?
Observational (n=102)
No
Does beta-blocker therapy impact the central:peripheral blood pressure ratio in patients undergoing coronary angiography?
Beta-blocker therapy is associated with a significantly lower central:peripheral systolic blood pressure ratio in patients undergoing coronary angiography.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in angiography patients; prospective trials needed before any practice implications.
Aim: The study aimed to propose the ratio of central blood pressure:peripheral blood pressure as a novel index to predict cardiovascular risk. We additionally attempted to determine the impact of beta-blocker therapy on this ratio.Materials and Methods: This was a prospective, single-centre study conducted between August 2019__ and December 2019. A total of 102 patients undergoing cath-lab procedures such as coronary angiography (CAG), percutaneous coronary intervention were studied. Central blood pressure was invasively measured from the radial artery. Peripheral blood pressure was also measured from the right arm radial artery using invasive pressure transducer. Patients were divided into two groups as follows: (i) beta-blocker group to receive beta-blocker treatment (n = 82) and (ii) nonbeta-blocker group that did not receive beta-blocker treatment (n = 20).Results: The mean age of the study participants was 55.7 ± 10.0 years. Males constituted 80 (78.4%) patients of the study population. The central:peripheral blood pressure ratios for systolic and diastolic blood pressure were 0.88 ± 0.1 and 0.93 ± 0.2 (P = 0.004), respectively. Systolic blood pressure ratios for the beta-blocker and nonbeta-blocker groups were 0.89 ± 0.1 and 0.93 ± 0.2 (P = 0.016), respectively. Similarly, diastolic blood pressure ratios for the beta-blocker and nonbeta-blocker groups were 0.84 ± 0.1 and 0.95 ± 0.1 (P = 0.770), respectively.Conclusions: This novel ratio of central:peripheral blood pressure may serve as a precursor of cardiovascular risk. This ratio may give a clue to relationship between central and peripheral blood pressure.
No takes yet. Share an insight, caveat, or question.
Chaudhary et al. (2020) conducted an observational in Patients undergoing coronary angiography or percutaneous coronary intervention (n=102). Beta-blocker therapy vs. No beta-blocker therapy was evaluated on Central-to-peripheral systolic blood pressure ratio (p=0.016). Beta-blocker therapy in patients undergoing coronary angiography was associated with a lower central-to-peripheral systolic blood pressure ratio compared to no beta-blockers (0.89 vs 0.93; P=0.016).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: